An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
Public ClinicalTrials.gov record NCT03491150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In the BN40031 OLE study, a dose of crenezumab of 60 mg/kg intravenous (IV) every 4 weeks (Q4W) will be offered to all participants who complete Study BN29552 or BN29553 and who meet eligibility criteria in order to evaluate safety in participants on long-term crenezumab treatment and to investigate the effect of crenezumab on the underlying disease process and disease course as an exploratory efficacy objective.
Study identification
- NCT ID
- NCT03491150
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 11, 2018 (Actual)
- Primary completion
- May 31, 2019 (Actual)
- Completion
- May 31, 2019 (Actual)
- Last update posted
- Jul 13, 2020
2018 – 2019
United States locations
- U.S. sites
- 32
- U.S. states
- 15
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shankle Clinic | Newport Beach | California | 92663 | — |
| Anderson Clinical Research, Inc. | Redlands | California | 92374 | — |
| University of California, Davis; Alzheimers Disease Center, Department of Neurology | Sacramento | California | 95817 | — |
| UCSF - Memory and Aging Center | San Francisco | California | 94158 | — |
| Neurological Research Inst | Santa Monica | California | 90404 | — |
| Associated Neurologists PC - Danbury | Danbury | Connecticut | 06810 | — |
| Institute for Neurodegenerative Disorders | New Haven | Connecticut | 06510 | — |
| Yale University School Of Medicine | New Haven | Connecticut | 06510 | — |
| Research Center for Clinical Studies, Inc. | Norwalk | Connecticut | 06851 | — |
| Bradenton Research Center | Bradenton | Florida | 34205 | — |
| Brain Matters Research, Inc. | Delray Beach | Florida | 33445 | — |
| Alzheimer's Research and Treatment Center | Lake Worth | Florida | 33414 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Bioclinica Research | Orlando | Florida | 32806 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Stedman Clinical Trials, LLC | Tampa | Florida | 33613 | — |
| NeuroStudies.net, LLC | Decatur | Georgia | 30033 | — |
| Alexian Brothers Neurosci Inst | Elk Grove Village | Illinois | 60007 | — |
| Southern Illinois University, School of Medicine | Springfield | Illinois | 62702 | — |
| MidAmerica Neuroscience Institute | Prairie Village | Kansas | 66206 | — |
| MMP Neurology | Scarborough | Maine | 04074 | — |
| Precise Research Centers | Flowood | Mississippi | 39232 | — |
| The Cognitive and Research Center of New Jersey | Springfield | New Jersey | 07081 | — |
| Advanced Memory Research Institute of NJ | Toms River | New Jersey | 08755 | — |
| Behavioral Health Research | Charlotte | North Carolina | 28211 | — |
| Guilford Neurologic Associates | Greensboro | North Carolina | 27401 | — |
| Oklahoma Clinical Research | Oklahoma City | Oklahoma | 73112 | — |
| Summit Research Network Inc. | Portland | Oregon | 97210 | — |
| Abington Neurological Associates | Willow Grove | Pennsylvania | 19090 | — |
| Senior Adults Specialty Research | Austin | Texas | 78757 | — |
| Sentara Medical Group | Norfolk | Virginia | 23507 | — |
| National Clinical Research Inc.-Richmond | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03491150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 13, 2020 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03491150 live on ClinicalTrials.gov.